UK Markets open in 54 mins

Global Rat Model Market Trajectory & Analytics, 2012-2019 & 2020-2027

Research and Markets
·3-min read

Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) -- The "Rat Model - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Rat Model estimated at US$510 Million in the year 2020, is projected to reach a revised size of US$815 Million by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027.

Knockout, one of the segments analyzed in the report, is projected to record a 7.8% CAGR and reach US$205.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Outbred segment is readjusted to a revised 7.2% CAGR for the next 7-year period.

The U. S. Market is Estimated at $150.7 Million, While China is Forecast to Grow at 6.4% CAGR

The Rat Model market in the U. S. is estimated at US$150.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$142.2 Million by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 5.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Inbred Segment to Record 6.4% CAGR

In the global Inbred segment, USA, Canada, Japan, China and Europe will drive the 6.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$54.3 Million in the year 2020 will reach a projected size of US$84.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$93.6 Million by the year 2027.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

  • Biomere

  • Charles River Laboratories International, Inc.

  • Covance, Inc.

  • Envigo, Inc.

  • Genoway S. A.

  • Horizon Discovery Group PLC

  • Janvier Labs

  • Taconic Biosciences, Inc.

  • Transposagen Biopharmaceuticals, Inc.

  • Transviragen, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares

  • Rat Model Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 31

For more information about this report visit https://www.researchandmarkets.com/r/3p9v2u

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900